Federal award
CEPHEID
W81K0023F0180
Contract
Obligated and Ceiling
- Obligated (net)
- $733,519.78
- Ceiling (potential value, not spending)
- $733,519.78
- Current value
- $733,519.78
- Gross positive obligations
- $1,404,461.44
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CEPHEID · W6HQTMWB9Q28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- DANAHER CORP · C81ZDK1LL4G7
- Awarding agency
- Department of War · sub-agency 2100 · office W81K00
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0023F0180
- Parent vehicle (IDV PIID)
- W81K0023D0005
- Award type code
- C
- Actions
- 4 · Aug 18, 2023 to Mar 26, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History4
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 26, 2025 | FY2025 | P00003 | C | −$670,941.66 | — |
| Nov 29, 2023 | FY2024 | P00002 | C | $1,404,461.44 | — |
| Sep 25, 2023 | FY2023 | P00001 | C | $0.00 | — |
| Aug 18, 2023 | FY2023 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.